Johnson & Johnson Taps Emergent BioSolutions to Help Manufacture Its COVID-19 VaccineDr. Orelli is a Senior Biotech Specialist. He has written about biotech, pharmaceutical, and medical device companies for The Motley Fool since 2007. Follow @BiologyFool Johnson & Johnson (NYSE:JNJ) signed a contract to pay Emergent BioSolutions (NYSE:EBS) $135 million to help manufacture its vaccine to treat COVID-19, the disease caused by the …
News story posted on 2020-04-24T05:37:00.0000000Z
#LIVE: Day 6 of George Floyd #BLM Protests in Minneapolis St Paul Minnesota
Day 6 of George Floyd protests: Sunday, May 31, 2020 As crowds of protesters once again gathered at the Minneapolis, Minnesota site of Floyd's arrest and subsequent death. Shortly after 6:00 p.m., a semi-truck tanker drove into a crowd of protesters on the I-35W...
0 Comments